Sustained increases of plasma homocysteine, copper, and serum ceruloplasmin after coronary artery bypass grafting

Annals of Thoracic Surgery

Volumn 74, Issue 5, 2002, Pages 1553-1557

  Jeremy, Jamie Y ^a,b   Shukla, Nilima ^a   Angelini, Gianni D ^a   Day, Andrew ^a   Wan, Innes Y P ^a   Talpahewa, Sudath P ^a   Ascione, Raimondo ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CERULOPLASMIN; COPPER; CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; GRAFT FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; INFLAMMATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; VEIN GRAFT;

AGED; CARDIOPULMONARY BYPASS; CERULOPLASMIN; COPPER; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; VITAMIN B 12;

EID: 0036841885     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)03807-9     Document Type: Article

References (29)

1. Chambers JC, Seddon MD, Shah S. Homocysteine: A novel risk factor for vascular disease. J R Soc Med. 2001;94:10-3.
2. Ueland PM, Refsum H, Beresford SAA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000;73:324-32.
3. Emsley A, Plane F, Jackson C, Jeremy JY. Homocysteine, oxidant stress and vascular disease.Vasc Dis 1998;1:3-8.
4. Jeremy JY, Rowe D, Emsley AM, et al. Nitric oxide and vascular cell proliferation Cardiovasc Res 1999;43:658-65.
5. Jeremy JY, Mehta D, Bryan AJ, Angeiini GD. Platelets and saphenous vein graft failure following coronary artery bypass graft surgery. Platelets 1997;8:295-309.
6. Iwama Y, Mokuno H, Yokoi H, et al. Elevated levels of plasma homocysteine related to saphenous vein graft disease after coronary artery bypass graft surgery. J Cardiol 1998;32:357-62.
7. Loscalzo J. The oxidant stress of hyperhomocysteineamia. J Clin Invest 1996;98:5-7.
8. Chambers JC, McGregor A, Jean-Marie J, et al. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinaemia: an effect reversible with vitamin C therapy. Circulation 1999;99:1156-60.
9. Emsley AM, Jeremy JY, Gomes GN, et al. Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta. Br J Pharmacol 1999;126:1034-40.
10. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986;77:1370-6.
11. Reunanen A, Knekt P, Aatrn R-K. Serum ceruloplasmin level and the risk of myocardial infarction and stroke. Am J Epidemiol 1992;136:1820-56.
12. Caputo M, Bryan AJ, Calafiore AM, et al. Intermittent antegrade hyperkalaemic warm blood cardioplegia supplemented with magnesium prevents myocardial substrate derangement in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 1998;14:596-601.
13. Calafiore AM, Di Giammarco G, Teodori G, et al. Recent advances in multivessel coronary grafting without cardiopulmonary bypass. Heart Surg Forum 1998;1:20-5.
14. Watters PR, Ascione R, Ryder IG, et al. Haemodynamic changes during beating heart coronary surgery with the "Bristol Technique." Eur J Cardiothorac Surg 2001;19:34-40.
15. Fiskeerstrand T, Refsum H, Kvalheim G, et al. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability. Clin Chem 1993;39:263-71.
16. Delves HT. Atomic absorption spectroscopy in clinical analysis. Ann Clin Biochem 1999;24:529-51.
17. Bowers LD, Wong ET. Kinetic serum creatinine assays. II. A critical evaluation and review. Clin Chem 1980;26:555-61.
18. Buffone GJ, Brett EM, Lewis SA, et al. Limitations of immunochemical measurement of ceruloplasmin. Clin Chem 1979; 25:749-51.
19. Ledue TB, Weiner DL, Sipe JD, et al. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 1998;35:745-53.
20. Minet JC, Bisse E, Aebischer CP, et al. Assessment of vitamin B12, folate, and vitamin B6 status and relation to sulfur amino acid metabolism in neonates. Am J Clin Nutr 2000;72:751-7.
21. Chao CL, Tsai HH, Lee CM, et al. The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis. Atherosclerosis 1999;147:379-86.
22. Antila H, Salo M, Nanto V, et al. Serum zinc, copper, selenium and bromide concentrations after coronary bypass operation. J Parent Ent Nutr 1990;14:85-9.
23. Zoccali C, Benedetto FA, Mallamaci F, et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens 2000;18:1207-13.
24. Mansoor MA, Bergmark CB, Haswell SJ, et al. Correlation between plasma total homocysteine and copper in patients with peripheral vascular disease. Clin Chem 2000;46:385-91.
25. Dudman NPB, Wilcken DEL. Increased plasma copper in patients with homocysteinuria due to cystathionine β-synthase deficiency. Clin Chim Acta 1983;127:105-13.
26. Hallbook T, Hedlin H. Changes in serum copper and serum caeruloplasmin concentration induced by surgical trauma. Acta Chir Scand 1980;146:371-3.
27. Wan S, Izzat MB Lee TW, et al. Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine responses and myocardial injury. Ann Thorac Surg 1999;68:52-7.
28. Jeremy JY, Yim AP, Wan S, Angelini GD. Oxidant stress, nitric oxide and vascular disease. J Cardiovasc Surg 2002; in press.
29. Cappelini-Bigazzi M, Ambrosio G, Musci G, et al. Ceruloplasmin impairs endothelium-dependent relaxation of rabbit aorta. Am J Physiol 1997;273:H2843-9.